FMP
Tilray Brands, Inc.
TLRY
NASDAQ
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
0.486 USD
0.0004 (0.08239%)
Mr. Irwin David Simon
Healthcare
Drug Manufacturers - Specialty & Generic
NASDAQ
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under...
0001731348
US88688T1007
88688T100
265 Talbot Street West
12064329325
CA
2,650
Jul 19, 2018
0001731348
NASDAQ
Drug Manufacturers -...
Healthcare
88688T100
US88688T1007
CA
0.49
1.99
36.41M
489.96M
-
0.43-2.31
4.83
-
-
-
-
-0.44
-
https://www.tilray.com
Rating Distribution
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Tony Dante
Apr 8, 2025
Tilray Brands, Inc. (NASDAQ:TLRY) is a prominent player in the cannabis industry, known for its diverse product offerings, including medical and recreational cannabis, hemp-based foods, and beverages. The company operates in a competitive market alongside other cannabis giants like Canopy Growth and Aurora Cannabis. Despite its strong market presence, Tilray faces financial challenges, as reflected in its recent earnings report. On April 8, 2025, Tilray reported an earnings per share (EPS) of -...
Stuart Mooney
Apr 3, 2025
Tilray Brands, Inc. (NASDAQ:TLRY) is a key player in the global lifestyle and consumer packaged goods sector, with a strong presence in the cannabis, beverage, and wellness industries. Operating in regions such as Canada, the United States, Europe, Australia, and Latin America, Tilray is set to release its quarterly earnings on April 8, 2025. Wall Street anticipates an earnings per share (EPS) loss of $0.04 and revenue of approximately $210.9 million. Despite the anticipated EPS loss, Tilray's ...
Gordon Thompson
Oct 9, 2024
Tilray Brands, Inc. (NASDAQ:TLRY) is a prominent player in the global cannabis industry, involved in various segments such as Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The company offers a wide range of products under different brand names, serving a diverse customer base that includes retailers, wholesalers, patients, and governments. The consensus price target for Tilray has remained stable at $2.50 over the past year, indicating a consistent ...
Andrew Wynn
Oct 8, 2024
Tilray Brands Inc. (NASDAQ: TLRY), a Canadian company, operates in the cannabis and alcohol sectors. It is set to release its quarterly earnings on October 10, 2024. Analysts predict an earnings per share (EPS) of -$0.05 and revenue of around $219.29 million. This release is crucial as the company faces challenges in its stock performance. Wall Street's projections for Tilray's quarter ending in August 2024 provide insights into its financial health. The company's price-to-earnings (P/E) ratio ...
The Motley Fool
Aug 25, 2024
Tilray's financial results have generally been unimpressive. Regulatory challenges make the company's prospects uncertain.
The Motley Fool
Aug 25, 2024
Tilray Brands is buying more beer brands to bolster its beverage portfolio. Its beverage business was the biggest source of revenue for Tilray last quarter.
The Motley Fool
Aug 22, 2024
Tilray Brands is acquiring businesses, working with regulators, and planning ahead. The acquisition of four craft beer breweries will shore up its U.S. operations.
Zacks Investment Research
Aug 21, 2024
The latest trading day saw Tilray Brands, Inc. (TLRY) settling at $1.89, representing a +1.07% change from its previous close.